Evolus projects $345M-$355M revenue for 2025 with new product launches
Source: SeekingAlpha
2025-05-07 19:14:13 ET
More on Evolus
- Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript
- Evolus: Two-Product Aesthetics Company With A Competitive Edge
- Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Evolus announces commercial launch of Evolysse
- Seeking Alpha’s Quant Rating on Evolus
Read the full article on Seeking Alpha
For further details see:
Evolus projects $345M-$355M revenue for 2025 with new product launches
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
-6.91% G/L:
$4.85 Last:
301,893 Volume:
$4.96 Open:
EOLS Latest News
EOLS Stock Data
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
